Search Orphan Drug Designations and Approvals
-
Generic Name: | sorafenib |
---|---|
Date Designated: | 02/28/2019 |
Orphan Designation: | Treatment of desmoid tumors/aggressive fibromatosis |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 04/22/2022 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bayer HealthCare Pharmaceuticals, Inc. 100 Bayer Boulevard P.O. Box 915 Whippany, New Jersey 07981 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-